{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:11:51Z","timestamp":1793797911390,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejps.2024.106783","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:36:26Z","timestamp":1714700186000},"page":"106783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis"],"prefix":"10.1016","volume":"198","author":[{"given":"Fei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106783_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174503","article-title":"Pirfenidone is a renal protective drug: mechanisms, signalling pathways, and preclinical evidence","volume":"911","author":"Bai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106783_bib0002","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/hep.30684","article-title":"Acute liver failure during pirfenidone treatment triggered by co-medication with esomeprazole","volume":"70","author":"Benesic","year":"2019","journal-title":"Hepatology"},{"issue":"135","key":"10.1016\/j.ejps.2024.106783_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/09059180.00011514","article-title":"Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis","volume":"24","author":"Cottin","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.ejps.2024.106783_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202000091","article-title":"Advances on nanomedicines for diagnosis and theranostics of hepatic fibrosis","volume":"1","author":"Dai","year":"2021","journal-title":"Adv. Nanobiomed. Res."},{"issue":"6958","key":"10.1016\/j.ejps.2024.106783_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.ejps.2024.106783_bib0006","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","article-title":"TGF-\u03b2 signalling and its role in cancer progression and metastasis","volume":"31","author":"Drabsch","year":"2012","journal-title":"Cancer Metast. Rev."},{"issue":"6","key":"10.1016\/j.ejps.2024.106783_bib0007","first-page":"2592","article-title":"Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells","volume":"61","author":"Eliaz","year":"2001","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.ejps.2024.106783_bib0008","first-page":"e3111","article-title":"Quantitative analysis of Cargo density in single-extracellular vesicles by imaging","volume":"8","author":"Kajimoto","year":"2018","journal-title":"Bio Protoc."},{"key":"10.1016\/j.ejps.2024.106783_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcdb.2016.12.001","article-title":"Extracellular vesicle mimetics: novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines","volume":"67","author":"Kim","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2024.106783_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03008208609001971","article-title":"The catabolic fate of hyaluronic acid","volume":"15","author":"Laurent","year":"1986","journal-title":"Connect. Tissue Res."},{"issue":"19","key":"10.1016\/j.ejps.2024.106783_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193065","article-title":"Hyaluronic acid-coated bovine milk exosomes for achieving tumor-specific intracellular delivery of miRNA-204","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2024.106783_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108032","article-title":"Hyaluronan decoration of milk exosomes directs tumor-specific delivery of doxorubicin","volume":"493","author":"Li","year":"2020","journal-title":"Carbohydr. Res."},{"issue":"4","key":"10.1016\/j.ejps.2024.106783_bib0013","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","article-title":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.ejps.2024.106783_bib0014","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","article-title":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ejps.2024.106783_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","article-title":"Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"18","key":"10.1016\/j.ejps.2024.106783_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184310","article-title":"Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis","volume":"25","author":"Pesce","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejps.2024.106783_bib0017","doi-asserted-by":"crossref","first-page":"e8100","DOI":"10.1371\/journal.pone.0008100","article-title":"Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk\/complications","volume":"4","author":"Sengupta","year":"2009","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.ejps.2024.106783_bib0018","doi-asserted-by":"crossref","first-page":"32259","DOI":"10.1074\/jbc.M300347200","article-title":"Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells","volume":"278","author":"Sugahara","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejps.2024.106783_bib0019","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2024.106783_bib0020","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/IJN.S171280","article-title":"CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGF\u03b2-induced HSC-T6 cells activation","volume":"14","author":"Ullah","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.ejps.2024.106783_bib0021","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajps.2022.07.004","article-title":"Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis","volume":"17","author":"Zhao","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2024.106783_bib0022","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1021\/acs.jproteome.1c00549","article-title":"Column-based technology for CD9-HPLC immunoaffinity isolation of serum extracellular vesicles","volume":"20","author":"Zhu","year":"2021","journal-title":"J. Proteome Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:44:21Z","timestamp":1717022661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"alternative-id":["S0928098724000940"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106783","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106783"}}